Together, these data suggest that injection of a predicted MMEJ-inducing sgRNA targeting dnajb6b was able to recapitulate many but not all modifying effects of GBT411/dnajb6b on bag3 cardiomyopathy. This evidence concerns the gene BAG3 and cardiomyopathy.